Evidence map›Paper›PMID 38524436›Full record

ReviewACS omega2024

Definitive Review of Nanobiochar.

Abhishek Kumar Chaubey, Tej Pratap, Brahmacharimayum Preetiva, Manvendra Patel, Jonathan S Singsit, Charles U Pittman, Dinesh Mohan

Abstract readReview
In one paragraph

Review in ACS omega, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Abhishek Kumar ChaubeySchool of Environmental Sciences, Jawaharlal Nehru University, New Delhi 110067, India.ORCID https://orcid.org/0000-0001-8265-3125
Tej PratapSchool of Environmental Sciences, Jawaharlal Nehru University, New Delhi 110067, India.
Brahmacharimayum PreetivaSchool of Environmental Sciences, Jawaharlal Nehru University, New Delhi 110067, India.
Manvendra PatelSchool of Environmental Sciences, Jawaharlal Nehru University, New Delhi 110067, India.ORCID https://orcid.org/0000-0002-5801-5526
Jonathan S SingsitSchool of Environmental Sciences, Jawaharlal Nehru University, New Delhi 110067, India.
Charles U PittmanDepartment of Chemistry, Mississippi State University, Mississippi State, Mississippi 39762, United States.
Dinesh MohanSchool of Environmental Sciences, Jawaharlal Nehru University, New Delhi 110067, India.ORCID https://orcid.org/0000-0002-3251-2946

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nanobiochar is an advanced nanosized biochar with enhanced properties and wide applicability for a variety of modern-day applications. Nanobiochar can be developed easily from bulk biochar through top-down approaches including ball-milling, centrifugation, sonication, and hydrothermal synthesis. Nanobiochar can also be modified or engineered to obtain "engineered nanobiochar" or biochar nanocomposites with enhanced properties and applications. Nanobiochar provides many fold enhancements in surface area (0.4-97-times), pore size (0.1-5.3-times), total pore volume (0.5-48.5-times), and surface functionalities over bulk biochars. These enhancements have given increased contaminant sorption in both aqueous and soil media. Further, nanobiochar has also shown catalytic properties and applications in sensors, additive/fillers, targeted drug delivery, enzyme immobilization, polymer production, etc. The advantages and disadvantages of nanobiochar over bulk biochar are summarized herein, in detail. The processes and mechanisms involved in nanobiochar synthesis and contaminants sorption over nanobiochar are summarized. Finally, future directions and recommendations are suggested.

Identifiers

PMID38524436
PMCPMC10955718

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.